{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:53:15Z","timestamp":1791287595975,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"DOI":"10.1038\/s41391-026-01162-z","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:17:02Z","timestamp":1791285422000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["How does PSA change after water vapor therapy? A systematic review and meta-analysis"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6126-9889","authenticated-orcid":false,"given":"Pietro","family":"Scilipoti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Chicaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Zorzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Rosiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5329-6445","authenticated-orcid":false,"given":"Marco","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Gandaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Panthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Traxer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steeve","family":"Doizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stessy","family":"Kutchukian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"1162_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-90229-3","volume":"15","author":"X Chen","year":"2025","unstructured":"Chen X, Yang S, He Z, Chen Z, Tang X, Lin Y, et al. Comprehensive analysis of the global, regional, and national burden of benign prostatic hyperplasia from 1990 to 2021. Sci Rep. 2025;15:5644. https:\/\/doi.org\/10.1038\/s41598-025-90229-3.","journal-title":"Sci Rep"},{"key":"1162_CR2","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/sj.pcan.4500806","volume":"8","author":"FC Lowe","year":"2005","unstructured":"Lowe FC, Batista J, Berges R, Chartier-Kastler E, Conti G, Desgrandchamps F, et al. Risk factors for disease progression in patients with lower urinary tract symptoms\/benign prostatic hyperplasia (LUTS\/BPH): a systematic analysis of expert opinion. Prostate Cancer Prostatic Dis. 2005;8:206\u20139. https:\/\/doi.org\/10.1038\/sj.pcan.4500806.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1162_CR3","first-page":"20","volume":"13","author":"H Lepor","year":"2011","unstructured":"Lepor H. Medical treatment of benign prostatic hyperplasia. Rev Urol. 2011;13:20\u201333.","journal-title":"Rev Urol"},{"key":"1162_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.eururo.2023.04.008","volume":"84","author":"S Gravas","year":"2023","unstructured":"Gravas S, Gacci M, Gratzke C, Herrmann TRW, Karavitakis M, Kyriazis I, et al. Summary paper on the 2023 European Association of Urology guidelines on the management of non-neurogenic male lower urinary tract symptoms. Eur Urol. 2023;84:207\u201322. https:\/\/doi.org\/10.1016\/j.eururo.2023.04.008.","journal-title":"Eur Urol"},{"key":"1162_CR5","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.eururo.2025.09.004","volume":"89","author":"A Franco","year":"2026","unstructured":"Franco A, Ditonno F, Manfredi C, Bologna E, Licari LC, Orecchia L, et al. Systematic review and pooled analysis of functional and sexual outcomes of minimally invasive surgical treatments for benign prostatic obstruction. Eur Urol. 2026;89:318\u201331. https:\/\/doi.org\/10.1016\/j.eururo.2025.09.004.","journal-title":"Eur Urol"},{"key":"1162_CR6","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41391-024-00900-5","volume":"28","author":"L Lambertini","year":"2025","unstructured":"Lambertini L, Sandulli A, Coco S, Paganelli D, Cadenar A, Dell\u2019oglio P, et al. Complication rate across the minimally invasive surgical treatments (MISTs): where do we stand? A systematic review of the literature. Prostate Cancer Prostatic Dis. 2025;28:639\u201351. https:\/\/doi.org\/10.1038\/s41391-024-00900-5.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1162_CR7","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.3390\/jcm14124254","volume":"14","author":"A Kaltsas","year":"2025","unstructured":"Kaltsas A, Giannakodimos I, Symeonidis EN, Deligiannis D, Stavropoulos M, Symeonidis A, et al. To Rez\u016bm or not to Rez\u016bm: a narrative review of water vapor thermal therapy for benign prostatic hyperplasia. J Clin Med. 2025;14:4254 https:\/\/doi.org\/10.3390\/jcm14124254.","journal-title":"J Clin Med"},{"key":"1162_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1590\/s1677-55382008000100007","volume":"34","author":"RC Fonseca","year":"2008","unstructured":"Fonseca RC, Gomes CM, Meireles EB, Freire GC, Srougi M. Prostate specific antigen levels following transurethral resection of the prostate. Int Braz J Urol. 2008;34:41\u201348. https:\/\/doi.org\/10.1590\/s1677-55382008000100007.","journal-title":"Int Braz J Urol"},{"key":"1162_CR9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/1756287218793084","volume":"10","author":"J Westwood","year":"2018","unstructured":"Westwood J, Geraghty R, Jones P, Rai BP, Somani BK. Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia. Ther Adv Urol. 2018;10:327\u201333. https:\/\/doi.org\/10.1177\/1756287218793084.","journal-title":"Ther Adv Urol"},{"key":"1162_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.urology.2018.12.041","volume":"126","author":"KT Mcvary","year":"2019","unstructured":"Mcvary KT, Rogers T, Roehrborn CG. Rez\u016bm water vapor thermal therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia: 4-year results from randomized controlled study. Urology. 2019;126:171\u20139. https:\/\/doi.org\/10.1016\/j.urology.2018.12.041.","journal-title":"Urology"},{"key":"1162_CR11","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/iju.15410","volume":"31","author":"M Samir","year":"2024","unstructured":"Samir M, Elaal AAA, Gad KAS, Basyony MW. Two-year follow-up comparing Rez\u016bm therapy versus bipolar transurethral resection of the prostate for treating benign prostatic hyperplasia. A prospective randomized study. Int J Urol. 2024;31:545\u201350. https:\/\/doi.org\/10.1111\/iju.15410.","journal-title":"Int J Urol"},{"key":"1162_CR12","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.urology.2015.05.046","volume":"86","author":"C Dixon","year":"2015","unstructured":"Dixon C, Cedano ER, Pacik D, Vit V, Varga G, Wagrell L, et al. Efficacy and safety of Rez\u016bm system water vapor treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology. 2015;86:1042\u20137. https:\/\/doi.org\/10.1016\/j.urology.2015.05.046.","journal-title":"Urology"},{"key":"1162_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.urology.2015.03.021","volume":"86","author":"LA Mynderse","year":"2015","unstructured":"Mynderse LA, Hanson D, Robb RA, Pacik D, Vit V, Varga G, et al. Rez\u016bm system water vapor treatment for lower urinary tract symptoms\/benign prostatic hyperplasia: validation of convective thermal energy transfer and characterization with magnetic resonance imaging and 3-dimensional renderings. Urology. 2015;86:122\u20137. https:\/\/doi.org\/10.1016\/j.urology.2015.03.021.","journal-title":"Urology"},{"key":"1162_CR14","doi-asserted-by":"publisher","first-page":"144","DOI":"10.5173\/ceju.2024.0224","volume":"78","author":"B Cakiroglu","year":"2025","unstructured":"Cakiroglu B, Acar \u0130C, Uyan\u0131k BS. Outcomes of Rezum water vapor therapy for benign prostate obstruction with 1-year follow-up: largest real-world data from Turkey. Cent Eur J Urol. 2025;78:144\u201350. https:\/\/doi.org\/10.5173\/ceju.2024.0224.","journal-title":"Cent Eur J Urol"},{"key":"1162_CR15","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.acuroe.2021.11.003","volume":"46","author":"E Fern\u00e1ndez-Guzm\u00e1n","year":"2022","unstructured":"Fern\u00e1ndez-Guzm\u00e1n E, Asensio Matas A, Capape Poves V, Rioja Zuazu J, Garrido Abad P, Mart\u00ednez-Salamanca JI, et al. Preliminary results of a national multicenter study on the treatment of LUTS secondary to benign prostatic hyperplasia using the Rez\u016bm steam system. Actas Urol Esp. 2022;46:310\u20136. https:\/\/doi.org\/10.1016\/j.acuroe.2021.11.003.","journal-title":"Actas Urol Esp"},{"key":"1162_CR16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00345-025-05793-0","volume":"43","author":"M Samir","year":"2025","unstructured":"Samir M, Mahmoud MA, Abdelmonem HA, Elrefaie M, Gad KA. A comparative analysis of the outcomes of Rez\u016bm therapy based on prostate size: a four-year retrospective analysis. World J Urol. 2025;43:443 https:\/\/doi.org\/10.1007\/s00345-025-05793-0.","journal-title":"World J Urol"},{"key":"1162_CR17","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/iju.70052","volume":"32","author":"J Abe","year":"2025","unstructured":"Abe J, Kyoda Y, Haga K, Sasao T, Nishiyama D, Nofuji S, et al. Water vapor energy therapy safely reduces urinary medication use: a multicenter retrospective real-world study in Japan (SCCOP study 24-01). Int J Urol. 2025;32:804\u201310. https:\/\/doi.org\/10.1111\/iju.70052.","journal-title":"Int J Urol"},{"key":"1162_CR18","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41391-017-0022-9","volume":"21","author":"D Mollengarden","year":"2018","unstructured":"Mollengarden D, Goldberg K, Wong D, Roehrborn C. Convective radiofrequency water vapor thermal therapy for benign prostatic hyperplasia: a single office experience. Prostate Cancer Prostatic Dis. 2018;21:379\u201385. https:\/\/doi.org\/10.1038\/s41391-017-0022-9.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1162_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.23736\/S2724-6051.22.05080-7","volume":"75","author":"L Cindolo","year":"2023","unstructured":"Cindolo L, Morselli S, Campobasso D, Conti E, Sebastiani G, Franzoso F, et al. One-year outcomes after water vapor thermal therapy for symptomatic benign prostatic hyperplasia in an unselected Italian multicenter cohort. Minerva Urol Nephrol. 2023;75:203\u20139. https:\/\/doi.org\/10.23736\/S2724-6051.22.05080-7.","journal-title":"Minerva Urol Nephrol"},{"key":"1162_CR20","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41391-022-00587-6","volume":"26","author":"D Campobasso","year":"2023","unstructured":"Campobasso D, Siena G, Chiodini P, Conti E, Franzoso F, Maruzzi D, et al. Composite urinary and sexual outcomes after Rezum: an analysis of predictive factors from an Italian multi-centric study. Prostate Cancer Prostatic Dis. 2023;26:410\u20134. https:\/\/doi.org\/10.1038\/s41391-022-00587-6.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1162_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41391-024-00836-w","volume":"28","author":"M Wolters","year":"2025","unstructured":"Wolters M, Krastel M, Winkler T, Idais H, Mazdak M, Tezval H, et al. Real-world experience of water vapour therapy (Rezum) in patients with benign prostatic enlargement: a retrospective single-center study. Prostate Cancer Prostatic Dis. 2025;28:160\u20136. https:\/\/doi.org\/10.1038\/s41391-024-00836-w.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1162_CR22","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/pros.24191","volume":"81","author":"M Ines","year":"2021","unstructured":"Ines M, Babar M, Singh S, Iqbal N, Ciatto M. Real-world evidence with The Rez\u016bm System: a retrospective study and comparative analysis on the efficacy and safety of 12 month outcomes across a broad range of prostate volumes. Prostate. 2021;81:956\u201370. https:\/\/doi.org\/10.1002\/pros.24191.","journal-title":"Prostate"},{"key":"1162_CR23","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s00345-021-03771-w","volume":"40","author":"A Bhat","year":"2022","unstructured":"Bhat A, Blachman-Braun R, Herrmann TRW, Shah HN. Are all procedures for benign prostatic hyperplasia created equal? A systematic review on post-procedural PSA dynamics and its correlation with relief of bladder outlet obstruction. World J Urol. 2022;40:889\u2013905. https:\/\/doi.org\/10.1007\/s00345-021-03771-w.","journal-title":"World J Urol"},{"key":"1162_CR24","doi-asserted-by":"publisher","unstructured":"Scilipoti P, Chicaud M, Abdallah MA, Wirtzfeld N, Moretto S, Kutchukian S, et al. Minimally invasive surgical therapies in patients with catheter-dependent urinary retention: a collaborative mini-review. Eur Urol Focus. 2026. https:\/\/doi.org\/10.1016\/j.euf.2026.03.003","DOI":"10.1016\/j.euf.2026.03.003"},{"key":"1162_CR25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.5213\/inj.2244176.088","volume":"26","author":"HE Lee","year":"2022","unstructured":"Lee HE, Kim B, Yoon HS, Suh J, Oh SJ. Outcome of patients with elevated prostate-specific antigen and lower urinary tract symptoms receiving holmium laser enucleation of the prostate. Int Neurourol J. 2022;26:248\u201357. https:\/\/doi.org\/10.5213\/inj.2244176.088.","journal-title":"Int Neurourol J"},{"key":"1162_CR26","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.euf.2023.03.018","volume":"9","author":"P Capogrosso","year":"2023","unstructured":"Capogrosso P, Ventimiglia E, Fallara G, Schifano N, Costa A, Candela L, et al. Holmium laser enucleation of the prostate is associated with complications and sequelae even in the hands of an experienced surgeon following completion of the learning curve. Eur Urol Focus. 2023;9:813\u201321. https:\/\/doi.org\/10.1016\/j.euf.2023.03.018.","journal-title":"Eur Urol Focus"},{"key":"1162_CR27","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.euf.2024.03.001","volume":"10","author":"G M\u00fcllhaupt","year":"2024","unstructured":"M\u00fcllhaupt G, Hechelhammer L, Graf N, Mordasini L, Schmid HP, Engeler DS, et al. Prostatic artery embolisation versus transurethral resection of the prostate for benign prostatic obstruction: 5-year outcomes of a randomised, open-label, noninferiority trial. Eur Urol Focus. 2024;10:788\u201395. https:\/\/doi.org\/10.1016\/j.euf.2024.03.001.","journal-title":"Eur Urol Focus"},{"key":"1162_CR28","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.urology.2009.06.039","volume":"74","author":"HM Elmansy","year":"2009","unstructured":"Elmansy HM, Elzayat EA, Sampalis JS, Elhilali MM. Prostatic-specific antigen velocity after holmium laser enucleation of the prostate: possible predictor for the assessment of treatment effect durability for benign prostatic hyperplasia and detection of malignancy. Urology. 2009;74:1105\u201310. https:\/\/doi.org\/10.1016\/j.urology.2009.06.039.","journal-title":"Urology"},{"key":"1162_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-57046-x","volume":"10","author":"NF Wasserman","year":"2020","unstructured":"Wasserman NF, Niendorf E, Spilseth B. Measurement of prostate volume with MRI (a guide for the perplexed): biproximate method with analysis of precision and accuracy. Sci Rep. 2020;10:575. https:\/\/doi.org\/10.1038\/s41598-019-57046-x.","journal-title":"Sci Rep"},{"key":"1162_CR30","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/pros.24367","volume":"82","author":"L Jia","year":"2022","unstructured":"Jia L, Strand DW, Goueli RS, Gahan JC, Roehrborn CG, Mauck RJ. PSA density is associated with BPH cellular composition. Prostate. 2022;82:1162\u20139. https:\/\/doi.org\/10.1002\/pros.24367.","journal-title":"Prostate"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01162-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01162-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01162-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:17:03Z","timestamp":1791285423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01162-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":30,"alternative-id":["1162"],"URL":"https:\/\/doi.org\/10.1038\/s41391-026-01162-z","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"10 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}